PURPOSE: The authors sought to define toxicity patterns according to the different accrual periods and clinical-therapeutic features in a large series of nasopharyngeal cancer (NPC) patients treated in two Italian centres over more than two decades. MATERIALS AND METHODS: A total of 883 patients consecutively treated with radiotherapy from 1977 to 2000 at the Florence (FLO) and Brescia (IRA) radiation oncology centres were studied. The crude incidence of late treatment toxicity in the different subgroups of patients was calculated and compared. RESULTS: Higher total and fractional doses and the "older" treatment techniques were related with an increased incidence of the main late effects of treatment. More recently treated patients experienced less treatment-related complications. CONCLUSIONS: Results of this benchmark study may have implications for understanding and developing new radiotherapy techniques, such as three-dimensional conformal radiotherapy (3D-CRT) and, in particular, intensity-modulated radiotherapy (IMRT) for NPC patients.
PURPOSE: The authors sought to define toxicity patterns according to the different accrual periods and clinical-therapeutic features in a large series of nasopharyngeal cancer (NPC) patients treated in two Italian centres over more than two decades. MATERIALS AND METHODS: A total of 883 patients consecutively treated with radiotherapy from 1977 to 2000 at the Florence (FLO) and Brescia (IRA) radiation oncology centres were studied. The crude incidence of late treatment toxicity in the different subgroups of patients was calculated and compared. RESULTS: Higher total and fractional doses and the "older" treatment techniques were related with an increased incidence of the main late effects of treatment. More recently treated patients experienced less treatment-related complications. CONCLUSIONS: Results of this benchmark study may have implications for understanding and developing new radiotherapy techniques, such as three-dimensional conformal radiotherapy (3D-CRT) and, in particular, intensity-modulated radiotherapy (IMRT) for NPCpatients.
Authors: Matthew B Parliament; Rufus A Scrimger; Stephanie G Anderson; Elizabeth C Kurien; Heather K Thompson; G Colin Field; John Hanson Journal: Int J Radiat Oncol Biol Phys Date: 2004-03-01 Impact factor: 7.038
Authors: M K Ng; S V Porceddu; A D Milner; J Corry; C Hornby; G Hope; D Rischin; L J Peters Journal: Clin Oncol (R Coll Radiol) Date: 2005-12 Impact factor: 4.126
Authors: Edmond H N Pow; Dora L W Kwong; Anne S McMillan; May C M Wong; Jonathan S T Sham; Lucullus H T Leung; W Keung Leung Journal: Int J Radiat Oncol Biol Phys Date: 2006-11-15 Impact factor: 7.038
Authors: G Sanguineti; F B Geara; A S Garden; S L Tucker; K K Ang; W H Morrison; L J Peters Journal: Int J Radiat Oncol Biol Phys Date: 1997-03-15 Impact factor: 7.038
Authors: E B Butler; B S Teh; W H Grant; B M Uhl; R B Kuppersmith; J K Chiu; D T Donovan; S Y Woo Journal: Int J Radiat Oncol Biol Phys Date: 1999-08-01 Impact factor: 7.038
Authors: Merav A Ben-David; Maximiliano Diamante; Jeffrey D Radawski; Karen A Vineberg; Cynthia Stroup; Carol-Anne Murdoch-Kinch; Samuel R Zwetchkenbaum; Avraham Eisbruch Journal: Int J Radiat Oncol Biol Phys Date: 2007-02-22 Impact factor: 7.038
Authors: Z Petrovich; J D Cox; B Roswit; R MacKintosh; R Middleton; M Ohanian; Y Rao; R W Byhardt; C Paig; J A del Regato Journal: Radiology Date: 1982-09 Impact factor: 11.105
Authors: S Tonoli; D Alterio; O Caspiani; A Bacigalupo; F Bunkheila; M Cianciulli; A Merlotti; A Podhradska; M Rampino; D Cante; L Bruschieri; R Gatta; S M Magrini Journal: Strahlenther Onkol Date: 2016-10-19 Impact factor: 3.621